Floatz logo

FILGRASTIM

Desmoplastic Small Round Cell Tumor

M.D. Anderson Cancer Centerprotein_peptidePhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

11 Active assets in the Desmoplastic Small Round Cell Tumor cohort.

Asset / SponsorPhaseRating
Cyclophosphamide
St. Jude Children's Research Hospital
Phase 2B
Fludarabine
St. Jude Children's Research Hospital
Phase 2B
ETOPOSIDE
M.D. Anderson Cancer Center
Phase 2CCC
Busulphan
M.D. Anderson Cancer Center
Phase 2CCC
TACROLIMUS
M.D. Anderson Cancer Center
Phase 2CCC

View all 24 →

Same molecule, other indications

FILGRASTIM is also rated in:

plasma cell myelomaDormant
BBB
Indicative ·
79 / 100
View asset →
Burkitt lymphomaDormant
BBB
Indicative ·
78 / 100
View asset →
Hodgkins lymphomaDormant
BBB
Indicative ·
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →